Genesis Therapeutics
Dr. Bell was principal founder and CEO of Alexion Pharmaceuticals for 23 years, discovering and developing life-transforming therapies, and delivering them to patients in over 50 countries. In 2008, he accepted on behalf of Alexion the Prix Galien USA Award for Best Biotechnology Product, the industry's highest accolade for pharmaceutical R&D — equivalent to the Nobel Prize.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.